ARK Genomic Revolution ETF (ARKG)

ARK Genomic Revolution ETF is trading at $43.09, down 2.16% on the session. The 50 day average sits at $39.33 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 62, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $36.62 with resistance near $44.47, so that band frames the current range. Average daily movement is roughly $1.46, or about 3.4% of the share price, which is what any stop placement has to allow for. The overall health score of 71 out of 100 combines a trend score of 75, momentum of 83 and a risk score of 46.

The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.